Pain Therapeutics
| eröffnet am: | 09.01.18 17:56 von: | Kurios1 |
| neuester Beitrag: | 25.04.21 00:01 von: | Jenniferhukga |
| Anzahl Beiträge: | 32 | |
| Leser gesamt: | 14635 | |
| davon Heute: | 2 | |
bewertet mit 0 Sternen |
||
|
Seite:
1
|
||
negatives Remoxy Panel Vote (3-14)
https://www.fiercebiotech.com/...eutics-abuse-deterrent-opioid-remoxy
http://investor.paintrials.com/news-releases/...018-financial-results
https://www.zacks.com/stock/news/318248/...-on-alzheimers-study-grant
Kapitalerhöhung zu 1,15$
"Pain Therapeutics, Inc. a biopharmaceutical company, today announced the closing of its previously announced registered direct offering of 8,860,778 shares of its common stock, which was priced at-the-market at a purchase price of $1.15 per share, for gross proceeds of approximately $10.19 million."
Wenn zu 6,8 Mio Aktien noch 8,9 Mio. neue Aktien hinzukommen kann man schon von einer enormen Verwässerung reden.
http://investor.paintrials.com/news-releases/...13-million-registered
Investor Call am 4. Oktober 2018
"Pain Therapeutics, Inc. , a biopharmaceutical company, today announced that it will host a live conference call to provide a strategic update regarding its business, its science and its pipeline. The call is scheduled to be held Thursday, October 4th at 10 AM Eastern time, 9 AM Central time."
https://www.nasdaq.com/de/symbol/ptie/real-time
Pain Therapeutics bekommt 3,5 Mio. $ "Forschungsgelder" vom NIH
Die Marktteilnehmer hatten offenbar andere News erwartet/erhofft.
https://investorshub.advfn.com/boards/...sg.aspx?message_id=143991091
widerstehen!
Danke.
https://www.sec.gov/Archives/edgar/data/1069530/...0181004xex99_1.htm
Meine Meinung.
